Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2021
Same author

Possible Modulatory Role of ARC Gene Variants in Mood Disorders.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2021
Same author

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2021
Same author

Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression.

Current medicinal chemistry·2021
Same author

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression.

Journal of affective disorders·2020
Same author

Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2020

Related Experiment Video

Updated: Feb 10, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K

Pharmacogenetics in Psychiatry.

Filippo Corponi1, Chiara Fabbri1, Alessandro Serretti1

  • 1Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Advances in Pharmacology (San Diego, Calif.)
|May 27, 2018
PubMed
Summary
This summary is machine-generated.

Pharmacogenetics uses genetic information to tailor mental illness treatments, improving drug efficacy and reducing side effects. Genome-wide studies offer promise for personalized medicine, though methods are still evolving.

Keywords:
AntidepressantsAntipsychoticsCandidate genesGWASMood stabilizersPharmacogeneticsPharmacogenomicsPrecision medicine

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex
07:42

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex

Published on: August 17, 2018

12.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex
07:42

Combined Transcranial Magnetic Stimulation and Electroencephalography of the Dorsolateral Prefrontal Cortex

Published on: August 17, 2018

12.5K

Area of Science:

  • Psychiatry
  • Genetics
  • Pharmacology

Background:

  • Mental illnesses pose significant individual and societal burdens.
  • Current psychotropic medications have limited efficacy and tolerability, impacting patient adherence.
  • Pharmacogenetics aims to personalize treatment by linking genetic data to drug response.

Purpose of the Study:

  • To explore the evolution and potential of pharmacogenetics in optimizing mental illness treatment.
  • To highlight the shift from candidate gene studies to genome-wide approaches.
  • To discuss the future of pharmacogenetic testing for personalized psychiatric care.

Main Methods:

  • Review of early candidate gene studies in psychotropic drug response.
  • Incorporation of genome-wide association studies (GWAS) and sequencing data.
  • Analysis of genetic variations influencing drug pharmacokinetics and pharmacodynamics.

Main Results:

  • Candidate gene studies yielded some reproducible biomarkers but were largely inconclusive.
  • Genome-wide approaches enable large-scale genetic variation analysis without prior hypotheses.
  • Promising findings have emerged, but data generation and analysis methods are still developing.

Conclusions:

  • Pharmacogenetics holds potential for personalized prescription of existing psychiatric medications.
  • Advancements in genomic technologies offer new insights into the genetic basis of mental illness.
  • Future pharmacogenetic tests will likely incorporate numerous genetic markers to capture complex gene interactions.